covid mrna vaccine - Search News

Order byBest matchMost fresh

FDA, Covid and vaccine

Digest more

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The new labels will expand that warning to certain age groups.

· 1d · on MSN

FDA expands COVID vaccine warning about possible side effect

STAT · 18h

FDA asks mRNA vaccine makers to widen age range for rare heart risk warning

· 18h

FDA panel recommends keeping COVID shots targeted to same strain as last year

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

wtvr · 16h

FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals

· 22h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 23h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

STAT1d

How do we know mRNA vaccines are safe and effective? An explainer

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

Live Science on MSN3d

2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.

Zacks Investment Research on MSN2d

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

Shares of prominent COVID-19 vaccine-makers Moderna MRNA, Pfizer PFE and BioNTech BNTX rose yesterday after the FDA issued new guidance for COVID-19 vaccine boosters. FDA’s New Requirements for COVID-19 Vaccines Although the agency continues to approve boosters based on immune response data for adults 65 and older,

2don MSN

FDA to limit covid shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

Health and Me on MSN3d

COVID Cases Rise In US, Trump Administration To Alter Vaccine Policy

The US Food and Drug Administration (FDA) is featuring an upcoming town hall, set to begin Tuesday at 1 pm in Washington.

BusinessMirror6d

Moderna’s combo Covid-flu shot shows promise on older adults, but FDA seeks more efficacy data

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators want to see data on whether the new vaccine protects people from getting sick.